Cargando…

Transcutaneous Vagal Stimulation in Knee Osteoarthritis (TRAVKO): Protocol of a Superiority, Outcome Assessor- and Participant-Blind, Randomised Controlled Trial

Current treatments for knee osteoarthritis (KOA) are partially effective. It is, therefore, necessary to find new strategies that can complement the existing ones. In this scenario, transcutaneous vagal stimulation (TVS) neurophysiological effects could be a helpful solution. However, there is no ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Bascour-Sandoval, Claudio, Gajardo-Burgos, Rubén, Muñoz-Poblete, Claudio, Riedemann-González, Pablo, Erices-Salas, Stephanie, Martínez-Molina, Agustín, Gálvez-García, Germán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819338/
https://www.ncbi.nlm.nih.gov/pubmed/36612632
http://dx.doi.org/10.3390/ijerph20010311
_version_ 1784865203161137152
author Bascour-Sandoval, Claudio
Gajardo-Burgos, Rubén
Muñoz-Poblete, Claudio
Riedemann-González, Pablo
Erices-Salas, Stephanie
Martínez-Molina, Agustín
Gálvez-García, Germán
author_facet Bascour-Sandoval, Claudio
Gajardo-Burgos, Rubén
Muñoz-Poblete, Claudio
Riedemann-González, Pablo
Erices-Salas, Stephanie
Martínez-Molina, Agustín
Gálvez-García, Germán
author_sort Bascour-Sandoval, Claudio
collection PubMed
description Current treatments for knee osteoarthritis (KOA) are partially effective. It is, therefore, necessary to find new strategies that can complement the existing ones. In this scenario, transcutaneous vagal stimulation (TVS) neurophysiological effects could be a helpful solution. However, there is no evidence of the efficacy of TVS in KOA. This trial aims to assess the efficacy of TVS in decreasing pain in participants aged 55 years or older with KOA. A randomised controlled, two-arm, double-blind (participants and outcome assessors) and clinical superiority trial will be conducted for 70 patients with KOA. All the participants will carry out an exercise program. It consists of 12 sessions over four weeks. In addition, they will be randomly assigned to (1) active TVS plus physical exercise or (2) sham TVS plus physical exercise. The application of active TVS consists of electronic stimulation of the auricular concha using a portable device. Sham TVS condition consists of the stimulation of the earlobe that does not cause neurophysiological effects. The primary outcome is the reduction in pain intensity. Additionally, functional capacity, physical performance, pain-related interference, pain-related distress, quality of life in older adults and global change will be measured. Assessments will be conducted at the beginning of the study (baseline), at the end of the intervention and after 1 and 3 months of follow-up. This trial will generate evidence regarding the efficacy of TVS in pain perception in individuals with KOA. This information will serve as an input in the clinical decision-making on the use or non-use of TVS in individuals with KOA. Thus, if the efficacy of TVS is confirmed, a new therapeutic tool may be included in the rehabilitation of individuals with KOA.
format Online
Article
Text
id pubmed-9819338
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98193382023-01-07 Transcutaneous Vagal Stimulation in Knee Osteoarthritis (TRAVKO): Protocol of a Superiority, Outcome Assessor- and Participant-Blind, Randomised Controlled Trial Bascour-Sandoval, Claudio Gajardo-Burgos, Rubén Muñoz-Poblete, Claudio Riedemann-González, Pablo Erices-Salas, Stephanie Martínez-Molina, Agustín Gálvez-García, Germán Int J Environ Res Public Health Protocol Current treatments for knee osteoarthritis (KOA) are partially effective. It is, therefore, necessary to find new strategies that can complement the existing ones. In this scenario, transcutaneous vagal stimulation (TVS) neurophysiological effects could be a helpful solution. However, there is no evidence of the efficacy of TVS in KOA. This trial aims to assess the efficacy of TVS in decreasing pain in participants aged 55 years or older with KOA. A randomised controlled, two-arm, double-blind (participants and outcome assessors) and clinical superiority trial will be conducted for 70 patients with KOA. All the participants will carry out an exercise program. It consists of 12 sessions over four weeks. In addition, they will be randomly assigned to (1) active TVS plus physical exercise or (2) sham TVS plus physical exercise. The application of active TVS consists of electronic stimulation of the auricular concha using a portable device. Sham TVS condition consists of the stimulation of the earlobe that does not cause neurophysiological effects. The primary outcome is the reduction in pain intensity. Additionally, functional capacity, physical performance, pain-related interference, pain-related distress, quality of life in older adults and global change will be measured. Assessments will be conducted at the beginning of the study (baseline), at the end of the intervention and after 1 and 3 months of follow-up. This trial will generate evidence regarding the efficacy of TVS in pain perception in individuals with KOA. This information will serve as an input in the clinical decision-making on the use or non-use of TVS in individuals with KOA. Thus, if the efficacy of TVS is confirmed, a new therapeutic tool may be included in the rehabilitation of individuals with KOA. MDPI 2022-12-25 /pmc/articles/PMC9819338/ /pubmed/36612632 http://dx.doi.org/10.3390/ijerph20010311 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Protocol
Bascour-Sandoval, Claudio
Gajardo-Burgos, Rubén
Muñoz-Poblete, Claudio
Riedemann-González, Pablo
Erices-Salas, Stephanie
Martínez-Molina, Agustín
Gálvez-García, Germán
Transcutaneous Vagal Stimulation in Knee Osteoarthritis (TRAVKO): Protocol of a Superiority, Outcome Assessor- and Participant-Blind, Randomised Controlled Trial
title Transcutaneous Vagal Stimulation in Knee Osteoarthritis (TRAVKO): Protocol of a Superiority, Outcome Assessor- and Participant-Blind, Randomised Controlled Trial
title_full Transcutaneous Vagal Stimulation in Knee Osteoarthritis (TRAVKO): Protocol of a Superiority, Outcome Assessor- and Participant-Blind, Randomised Controlled Trial
title_fullStr Transcutaneous Vagal Stimulation in Knee Osteoarthritis (TRAVKO): Protocol of a Superiority, Outcome Assessor- and Participant-Blind, Randomised Controlled Trial
title_full_unstemmed Transcutaneous Vagal Stimulation in Knee Osteoarthritis (TRAVKO): Protocol of a Superiority, Outcome Assessor- and Participant-Blind, Randomised Controlled Trial
title_short Transcutaneous Vagal Stimulation in Knee Osteoarthritis (TRAVKO): Protocol of a Superiority, Outcome Assessor- and Participant-Blind, Randomised Controlled Trial
title_sort transcutaneous vagal stimulation in knee osteoarthritis (travko): protocol of a superiority, outcome assessor- and participant-blind, randomised controlled trial
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819338/
https://www.ncbi.nlm.nih.gov/pubmed/36612632
http://dx.doi.org/10.3390/ijerph20010311
work_keys_str_mv AT bascoursandovalclaudio transcutaneousvagalstimulationinkneeosteoarthritistravkoprotocolofasuperiorityoutcomeassessorandparticipantblindrandomisedcontrolledtrial
AT gajardoburgosruben transcutaneousvagalstimulationinkneeosteoarthritistravkoprotocolofasuperiorityoutcomeassessorandparticipantblindrandomisedcontrolledtrial
AT munozpobleteclaudio transcutaneousvagalstimulationinkneeosteoarthritistravkoprotocolofasuperiorityoutcomeassessorandparticipantblindrandomisedcontrolledtrial
AT riedemanngonzalezpablo transcutaneousvagalstimulationinkneeosteoarthritistravkoprotocolofasuperiorityoutcomeassessorandparticipantblindrandomisedcontrolledtrial
AT ericessalasstephanie transcutaneousvagalstimulationinkneeosteoarthritistravkoprotocolofasuperiorityoutcomeassessorandparticipantblindrandomisedcontrolledtrial
AT martinezmolinaagustin transcutaneousvagalstimulationinkneeosteoarthritistravkoprotocolofasuperiorityoutcomeassessorandparticipantblindrandomisedcontrolledtrial
AT galvezgarciagerman transcutaneousvagalstimulationinkneeosteoarthritistravkoprotocolofasuperiorityoutcomeassessorandparticipantblindrandomisedcontrolledtrial